Solubility and stability of dalcetrapib in vehicles and biological media

被引:18
作者
Gross, Guenter [1 ]
Tardio, Joseph [1 ]
Kuhlmann, Olaf [1 ]
机构
[1] F Hoffmann La Roche Ltd, CH-4070 Basel, Switzerland
关键词
Dalcetrapib; Dalcetrapib solubility; Dalcetrapib stability; Biorelevant media; Biological media; Cholesteryl ester transfer protein (CETP); DISSOLUTION; EXPRESSION; PLASMA; DRUGS; FOOD;
D O I
10.1016/j.ijpharm.2012.07.071
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dalcetrapib solubility was determined in aqueous and in non-aqueous vehicles and in biorelevant media. In a pure aqueous environment the solubility was low but could be increased by addition of surfactants or complexing agents. This was also reflected in the solubility seen in simulated gastrointestinal (GI) fluids, with almost no solubility in simulated gastric fluid, but reasonable solubilisation in simulated intestinal fluids containing lecithin and bile salt. Additionally, the stability of dalcetrapib was determined in simulated GI fluids with and without pancreatic lipase. In solutions without lipase, dalcetrapib was slowly hydrolysed, but in the presence of lipase the hydrolysis rate was significantly faster depending on pH and enzyme activity. In biological fluids, dissolved dalcetrapib appeared to behave similarly being rapidly hydrolysed in human intestinal fluids with a half-life below 20 s with no degradation observed in human gastric fluids at low pH. The results provide supportive evidence that absorption is higher under fed conditions and indicate lipase inhibitors might interfere with oral absorption of dalcetrapib. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 21 条
[1]  
Bentley D.B., 2012, J CARDIOVASC PHARM
[2]   Physiological parameters governing the action of pancreatic lipase [J].
Brownlee, Iain A. ;
Forster, Deborah J. ;
Wilcox, Matthew D. ;
Dettmar, Peter W. ;
Seal, Chris J. ;
Pearson, Jeff P. .
NUTRITION RESEARCH REVIEWS, 2010, 23 (01) :146-154
[3]   How gastric lipase, an interfacial enzyme with a Ser-His-Asp catalytic triad, acts optimally at acidic pH [J].
Chahinian, H ;
Snabe, T ;
Attias, C ;
Fojan, P ;
Petersen, SB ;
Carrière, F .
BIOCHEMISTRY, 2006, 45 (03) :993-1001
[4]  
Derks M., 2010, CLIN PHARM THER, V87
[5]   Effects of Food Intake on the Pharmacokinetic Properties of Dalcetrapib: Findings From Three Phase I, Single-Dose Crossover Studies in Healthy Volunteers [J].
Derks, Michael ;
Kawamura, Hitoshi ;
Abt, Markus ;
Meneses-Lorente, Georgina ;
Phelan, Mary ;
Ishikawa, Tomohiro .
CLINICAL THERAPEUTICS, 2011, 33 (06) :754-765
[6]   Solution Stability - Plasma, Gastrointestinal, Bioassay [J].
Di, Li ;
Kerns, Edward H. .
CURRENT DRUG METABOLISM, 2008, 9 (09) :860-868
[7]   Gastric juice as a dissolution medium: Surface tension and pH [J].
Efentakis, M ;
Dressman, JB .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1998, 23 (02) :97-102
[8]   Structure and function of gastro-intestinal lipases [J].
Embleton, JK ;
Pouton, CW .
ADVANCED DRUG DELIVERY REVIEWS, 1997, 25 (01) :15-32
[9]   Orlistat-associated adverse effects and drug interactions - A critical review [J].
Filippatos, Theodosios D. ;
Derdemezis, Christos S. ;
Gazi, Irene F. ;
Nakou, Eleni S. ;
Mikhailidis, Dimitri P. ;
Elisaf, Moses S. .
DRUG SAFETY, 2008, 31 (01) :53-65
[10]   Salivary esterase activity and its association with the biodegradation of dental composites [J].
Finer, Y ;
Santerre, JP .
JOURNAL OF DENTAL RESEARCH, 2004, 83 (01) :22-26